{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T10:22:07Z","timestamp":1779358927662,"version":"3.51.4"},"reference-count":15,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2018,7,14]],"date-time":"2018-07-14T00:00:00Z","timestamp":1531526400000},"content-version":"vor","delay-in-days":1,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,11,1]]},"DOI":"10.1093\/gastro\/goy020","type":"journal-article","created":{"date-parts":[[2018,5,9]],"date-time":"2018-05-09T03:11:13Z","timestamp":1525835473000},"page":"284-290","source":"Crossref","is-referenced-by-count":12,"title":["Well-controlled autoimmune hepatitis treatment withdrawal may be safely accomplished without liver-biopsy guidance"],"prefix":"10.1093","volume":"6","author":[{"given":"John","family":"Guirguis","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Blake Medical Center, Bradenton, FL, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yilien","family":"Alonso","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Ochsner Health System, New Orleans, LA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rocio","family":"Lopez","sequence":"additional","affiliation":[{"name":"Department of Quantitative Health Sciences, Cleveland Clinic, Cleveland, OH, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William","family":"Carey","sequence":"additional","affiliation":[{"name":"Digestive Disease Institute, Department of Gastroenterology and Hepatology, Cleveland Clinic, Cleveland, OH, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2018,7,13]]},"reference":[{"key":"key\n\t\t\t\t2018110909060600800_goy020-B1","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1002\/hep.23584","article-title":"American association for the study of liver disease: diagnosis and management of autoimmune hepatitis","volume":"51","author":"Manns","year":"2010","journal-title":"Hepatology"},{"key":"key\n\t\t\t\t2018110909060600800_goy020-B2","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1111\/j.1572-0241.2004.30457.x","article-title":"Factors predicting relapse and poor outcome in type I autoimmune hepatitis: role of cirrhosis development, patterns of transaminases during remission and plasma cell activity in the liver biopsy","volume":"99","author":"Verma","year":"2004","journal-title":"Am J Gastroenterol"},{"key":"key\n\t\t\t\t2018110909060600800_goy020-B3","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1053\/jhep.2002.32485","article-title":"Sustained remission after corticosteroid therapy for type 1 autoimmune hepatitis: a retrospective analysis","volume":"35","author":"Czaja","year":"2002","journal-title":"Hepatology"},{"key":"key\n\t\t\t\t2018110909060600800_goy020-B4","first-page":"3609","article-title":"A retrospective analysis of 1.011 percutaneous liver biopsies performed in patients with liver transplantation or liver disease: ultrasonography can reduce complications?","volume":"20","author":"Filingeri","year":"2016","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"key\n\t\t\t\t2018110909060600800_goy020-B5","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.jhep.2013.05.015","article-title":"Slow regression of liver fibrosis presumed by repeated biomarkers after virological cure in patients with chronic hepatitis C","volume":"59","author":"Poynard","year":"2013","journal-title":"J Hepatol"},{"key":"key\n\t\t\t\t2018110909060600800_goy020-B6","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1111\/j.1572-0241.2007.01153.x","article-title":"Improving the end point of corticosteroid therapy in type 1 autoimmune hepatitis to reduce the frequency of relapse","volume":"102","author":"Montano-Loza","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"key\n\t\t\t\t2018110909060600800_goy020-B7","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.pathol.2016.05.001","article-title":"The utility of repeat liver biopsy in autoimmune hepatitis: a series of 20 consecutive cases","volume":"48","author":"Putra","year":"2016","journal-title":"Pathology"},{"key":"key\n\t\t\t\t2018110909060600800_goy020-B8","doi-asserted-by":"crossref","first-page":"4651","DOI":"10.3748\/wjg.v22.i19.4651","article-title":"Auto immune hepatitis","volume":"22","author":"van Gerven","year":"2016","journal-title":"World J Gastroenterol"},{"key":"key\n\t\t\t\t2018110909060600800_goy020-B9","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/j.jhep.2015.06.030","article-title":"EASL clinical practice guidelines: autoimmune hepatitis","volume":"63","author":"European Association for the Study of the Liver","year":"2015","journal-title":"J Hepatol"},{"key":"key\n\t\t\t\t2018110909060600800_goy020-B10","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1136\/gut.2010.235259","article-title":"British Society of Gastroenterology. British Society of Gastroenterology (BSG) guidelines for management of autoimmune hepatitis","volume":"60","author":"Gleeson","year":"2011","journal-title":"Gut"},{"key":"key\n\t\t\t\t2018110909060600800_goy020-B11","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1097\/MCG.0b013e318154af74","article-title":"Serologic markers compared with liver biopsy for monitoring disease activity in autoimmune hepatitis","volume":"42","author":"Luth","year":"2008","journal-title":"J Clin Gastroenterol"},{"key":"key\n\t\t\t\t2018110909060600800_goy020-B12","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1111\/1751-2980.12085","article-title":"Autoimmune hepatitis in southern Israel: a 15-year multicenter study","volume":"14","author":"Delgado","year":"2013","journal-title":"J Dig Dis"},{"key":"key\n\t\t\t\t2018110909060600800_goy020-B13","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.jhep.2014.10.018","article-title":"Patient selection based on treatment duration and liver biochemistry increases success rates after treatment withdrawal in autoimmune hepatitis","volume":"62","author":"Hartl","year":"2015","journal-title":"J Hepatol"},{"key":"key\n\t\t\t\t2018110909060600800_goy020-B14","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.jhep.2012.09.009","article-title":"Relapse is almost universal after withdrawal of immunosuppressive medication in patients with autoimmune hepatitis in remission","volume":"58","author":"van Gerven","year":"2013","journal-title":"J Hepatol"},{"key":"key\n\t\t\t\t2018110909060600800_goy020-B15","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1016\/j.jhep.2011.09.024","article-title":"Clinical evidence for the regression of liver fibrosis","volume":"56","author":"Ellis","year":"2012","journal-title":"J Hepatol"}],"container-title":["Gastroenterology Report"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/gastro\/article-pdf\/6\/4\/284\/26468817\/goy020.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,6]],"date-time":"2024-07-06T16:35:33Z","timestamp":1720283733000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/gastro\/article\/6\/4\/284\/5053959"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,13]]},"references-count":15,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2018,7,13]]},"published-print":{"date-parts":[[2018,11,1]]}},"URL":"https:\/\/doi.org\/10.1093\/gastro\/goy020","relation":{},"ISSN":["2052-0034"],"issn-type":[{"value":"2052-0034","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,11]]},"published":{"date-parts":[[2018,7,13]]}}}